Covid-19 in a patient with multiple sclerosis treated with natalizumab: May the blockade of integrins have a protective role?

被引：48

作者：

Aguirre, Clara ^{[1
]}

Meca-Lallana, Virginia ^{[1
]}

Barrios-Blandino, Ana ^{[2
]}

del Rio, Beatriz ^{[1
]}

Vivancos, Jose ^{[3
]}

机构：

[1] Hosp Univ La Princesa, Dept Neurol, Multiple Sclerosis Unit, Madrid, Spain

[2] Hosp Univ La Princesa, Dept Infect Dis, Madrid, Spain

[3] Hosp Univ La Princesa, Dept Neurol, Madrid, Spain

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 44卷

关键词：

Multiple Sclerosis; COVID-19; SARS-CoV-2; Natalizumab; Integrins;

D O I：

10.1016/j.msard.2020.102250

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The disease caused by the new coronavirus SARS-CoV-2 (COVID-19) is currently spread worldwide. Recent data supports SARS-CoV-2 may use integrins to enter human cells. Therefore, anti-integrins therapies might be an alternative against the infection. Natalizumab, approved for Multiple Sclerosis (MS) treatment, acts blocking alpha 4-integrin. We report a MS patient treated with natalizumab who develops COVID-19, with excellent recovery and repeated negative results in 5 consecutive microbiological studies. We postulate this may be due to the blockade of integrins induced by natalizumab.

引用

页数：2

共 8 条

[1] COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
Borriello, Giovanna
Ianniello, Antonio
[J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 41
[2] Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic
Brownlee, Wallace
Bourdette, Dennis
Broadley, Simon
Killestein, Joep
Ciccarelli, Olga
[J]. NEUROLOGY, 2020, 94 (22) : 949 - 952
[3] Beyond RGD: virus interactions with integrins
Hussein, Hosni A. M.
Walker, Lia R.
Abdel-Raouf, Usama M.
Desouky, Sayed A.
Montasser, Abdel Khalek M.
Akula, Shaw M.
[J]. ARCHIVES OF VIROLOGY, 2015, 160 (11) : 2669 - 2681
[4] COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, Puja
McAuley, Daniel F.
Brown, Michael
Sanchez, Emilie
Tattersall, Rachel S.
Manson, Jessica J.
[J]. LANCET, 2020, 395 (10229) : 1033 - 1034
[5] Sigrist C.J., 2020, POTENTIAL ROLE INTEG, V177
[6] An Italian programme for COVID-19 infection in multiple sclerosis
Sormani, Maria Pia
[J]. LANCET NEUROLOGY, 2020, 19 (06) : 481 - 482
[7] SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression
Tresoldi, Ilaria
Sangiuolo, Carla F.
Manzari, Vittorio
Modesti, Andrea
[J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1741 - 1742
[8] Zhou Peng, 2020, NATURE, V579, P270, DOI [DOI 10.1038/s41586-020-2012-7, 10.1038/s41586-020-2012-7]

← 1 →